|1.||Glorieux, Francis H: 26 articles (08/2015 - 11/2002)|
|2.||Rauch, Frank: 24 articles (08/2015 - 01/2002)|
|3.||Lin, Shien-Fong: 16 articles (10/2015 - 05/2002)|
|4.||Lipton, Allan: 14 articles (06/2013 - 02/2003)|
|5.||Coleman, Robert E: 14 articles (11/2012 - 12/2002)|
|6.||Chen, Peng-Sheng: 12 articles (10/2015 - 05/2002)|
|7.||Moore, David R: 11 articles (11/2015 - 05/2006)|
|8.||Terpos, Evangelos: 11 articles (10/2015 - 01/2003)|
|9.||Chang, Po-Cheng: 10 articles (10/2015 - 04/2011)|
|10.||Weiss, James N: 9 articles (10/2015 - 05/2002)|
10/01/2004 - "Pamidronate was associated with a marked improvement in function and well-being, and a reduction of pain and use of other medications in all patients, with no significant adverse effects. "
01/01/1994 - "Marked improvement in bone pain was observed in 44% of patients receiving pamidronate compared to 30% in controls (p = 0.025). "
01/01/2014 - "The proportion of responders, changes in worst pain, and pain interference with daily function were also significantly improved for pamidronate 180 mg compared with placebo. "
04/01/2009 - "Pamidronate was associated with a reduction in bone pain and a significant reduction in BALP in all patients at the end of follow-up (P < 0.02). "
06/01/2000 - "In the past 10 years, the bisphosphonate pamidronate has been used by infusion for fibrous dysplasia (two courses per year), with good results with respect to pain and, in about 50% of patients, the refilling of osteolytic lesions."
|2.||Hypercalcemia (Milk Alkali Syndrome)
08/01/1991 - "All three are useful for the treatment of hypercalcemia, but pamidronate seems to be the most effective. "
11/01/2007 - "Pamidronate therapy seems to be safe in the short-term and effective in helping control hypercalcemia even in the very premature infant, allowing for planned surgical intervention when it becomes feasible."
06/01/1996 - "We report two cases of PHPT in which intravenous pamidronate effectively reduced hypercalcemia and significantly improved the clinical symptoms. "
01/01/1988 - "We conclude that APD is a valuable supplement to the treatment of malignant hypercalcemia in that it may be effective when traditional therapies have failed."
12/01/2002 - "Although treatment of hypercalcemia with pamidronate is palliative, it is effective against the deterioration of quality of life."
|3.||Neoplasm Metastasis (Metastasis)
11/01/2008 - "Findings from this study show that pamidronate in dose 90 mg is effective in treatment of different stages of bone metastases. "
08/01/2001 - "Intravenous pamidronate is currently the standard treatment for patients with bone metastases, and is effective in reducing the frequency of a variety of skeletal-related events. "
02/01/2008 - "However, our preliminary trial of an intravenous bisphosphonate, pamidronate, showed effective inhibition of bone metastases. "
01/01/2003 - "However, our preliminary trial of intravenous bisphosphonate with pamidronate showed effective inhibition of bone metastases. "
06/01/2013 - "Following the initial diagnosis of bone metastasis, 8 patients (12.7%) were started on zolendronic acid, 50 patients (80.6%) were started on pamidronate, and 4 (6.4%) received no treatment. "
|4.||Breast Neoplasms (Breast Cancer)
01/01/2000 - "Although pamidronate is effective in preventing a feared, common adverse outcome in metastatic breast cancer, its use is associated with high incremental costs per adverse event avoided. "
01/01/2000 - "Pamidronate is effective in reducing bony complications in patients with metastatic breast cancer who have known osteolytic lesions. "
07/01/2011 - "In a head-to-head trial in patients with breast cancer, ZOL demonstrated efficacy at least comparable with, and some benefits beyond those of, pamidronate. "
01/01/1991 - "The results indicate that reduced skeletal morbidity in breast cancer patients during pamidronate treatments is associated with an improvement in selective aspects of quality of life."
06/01/2015 - "In a study of screen film mammograms, we recently reported a novel feature from the pectoral muscle region to be associated with breast cancer risk independently of area percent density (APD). "
07/01/2003 - "Despite the proven efficacy of low-dose pamidronate in adults with osteoporosis, the efficacy of the low-dose regimen in children has not been studied. "
03/01/2006 - "We demonstrated that pamidronate therapy seems to be safe and beneficial in both spinal and peripheral skeleton osteoporosis in patients with OPPG. "
11/01/2003 - "These data suggest that pamidronate, at a monthly dose of 30 mg, is an effective treatment for thalassaemic osteoporosis."
11/01/2003 - "Pamidronate is an effective treatment for osteoporosis in patients with beta-thalassaemia."
02/01/2002 - "Bone densitometry is particularly effective for early detection of patients at risk for fracture and is of practical interest since patients with osteoporosis can now be treated with Pamidronate."
|2.||zoledronic acid (zoledronate)
|4.||Clodronic Acid (Clodronate)
|6.||Calcitonin (Calcitonin, Eel)
|9.||Alendronate (Alendronate Sodium)
|10.||ibandronic acid (Boniva)
|2.||Drug Therapy (Chemotherapy)
|3.||Continuous Ambulatory Peritoneal Dialysis (CAPD)